title: Buspirone use in the treatment of atomoxetine-induced bruxism.
authors.affiliation: 1 Department of Child and Adolescent Psychiatry, Faculty of Medicine, Ondokuz Mayıs University , Samsun, Turkey .
authors.forename: Murat
authors.initials: M
authors.lastname: Yüce
authors.forename: Koray
authors.initials: K
authors.lastname: Karabekiroğlu
authors.forename: Gökçe Nur
authors.initials: GN
authors.lastname: Say
authors.forename: Mahmut
authors.initials: M
authors.lastname: Müjdeci
authors.forename: Meral
authors.initials: M
authors.lastname: Oran
mesh_terms: D018759:Adrenergic Uptake Inhibitors / Q000009:adverse effects / Q000627:therapeutic use; D000069445:Atomoxetine Hydrochloride; D001289:Attention Deficit Disorder with Hyperactivity / Q000188:drug therapy*; D002012:Bruxism / Q000139:chemically induced / Q000188:drug therapy*; D002065:Buspirone / Q000627:therapeutic use*; D002648:Child; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D011437:Propylamines / Q000009:adverse effects* / Q000627:therapeutic use; D017366:Serotonin Receptor Agonists / Q000627:therapeutic use; D016896:Treatment Outcome
chemical_list: D018759:Adrenergic Uptake Inhibitors; D011437:Propylamines; D017366:Serotonin Receptor Agonists; D000069445:Atomoxetine Hydrochloride; D002065:Buspirone